Hugo Moser (scientist)
American neurologist and researcher
Hugo Wolfgang Moser (1924–2007) was a prominent neurologist and researcher known for his pioneering work in the field of neurogenetics. He made significant contributions to the understanding and treatment of adrenoleukodystrophy (ALD), a rare genetic disorder.
Early Life and Education[edit]
Hugo Moser was born in Berlin, Germany, in 1924. He emigrated to the United States with his family in 1934, escaping the rise of the Nazi regime. Moser pursued his undergraduate studies at Columbia University, where he developed an interest in the biological sciences. He later attended Harvard Medical School, earning his medical degree in 1950.
Career[edit]

Moser began his medical career at the Massachusetts General Hospital (MGH), where he completed his residency in neurology. During his time at MGH, he became deeply involved in research, focusing on the genetic and biochemical aspects of neurological diseases.
In 1976, Moser joined the Kennedy Krieger Institute in Baltimore, Maryland, where he served as the director of the Neurogenetics Research Center. His work at Kennedy Krieger was instrumental in advancing the understanding of ALD, a disorder that affects the myelin sheath of nerve cells.
Research on Adrenoleukodystrophy[edit]
Moser's most notable contribution to medical science was his research on adrenoleukodystrophy. He and his team identified the biochemical defect in ALD, which involves the accumulation of very long-chain fatty acids (VLCFAs) in the body. This discovery was crucial in developing diagnostic tests and potential treatments for the disease.
Moser was also involved in the development of Lorenzo's oil, a dietary therapy that helps manage the progression of ALD in some patients. His work laid the foundation for newborn screening programs for ALD, allowing for early detection and intervention.
Legacy and Honors[edit]

Throughout his career, Moser received numerous awards and honors for his contributions to neurology and genetics. He was a member of several prestigious medical societies and served on various advisory boards related to genetic research.
Moser's legacy continues through the ongoing research at the Kennedy Krieger Institute and the many lives improved by his work on ALD. His dedication to understanding and treating genetic disorders has had a lasting impact on the field of neurogenetics.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian